Bessent Forecasts Substantial Disinflation as Warsh Prepares to Lead Federal Reserve Thailand TrainBus Collision Safety Concerns and Potential Sector Implications High Energy Prices Could Challenge Europes AI Ambitions Against US and China DeepSeek Fears Overdone Why US AI Titans Are Poised to Recover Paul Tudor Jones Says No Chance Kevin Warsh Would Cut Fed Rates Stocks Edge Higher on Solid Fundamentals Market Rally Continues USCIS Updates Green Card Process Applicants Now Required to Return Home for Filing Gold Technical Outlook Traders Assess Key Levels Amid Market Uncertainty Pope Leos Encyclical on AI Draws Ethical Lines as Anthropic Attends Signing Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Unity Software Q1 2026 Earnings Narrower Loss Beats Estimates Stock Edges Higher HP Q1 2026 Earnings Significant EPS Miss Amid Challenging Drilling Environment SHC Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback Emerson Electric Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher COKE Q1 2026 Earnings EPS of 179 Reported Stock Edges Lower MNDO Q1 2025 Earnings EPS of 002 Reported Stock Edges Lower Olin Corporation OLN Edges Lower Consolidating Between Key Support and Resistance Levels ICON plc ICLR Surges 4 as Biotech Sector Momentum Drives Positive Price Action Doximity DOCS Rebounds Up 38 as Stock Tests Key Resistance Levels Roadzen Inc Warrants RDZNW Fall Sharply as Selling Pressure Intensifies Gibraltar Industries ROCK Surges 46 Key Resistance Level in Focus Blackrock Limited Duration Income Trust BLW Edges Higher Amid Steady Income Focus One Stop Systems Inc OSS Rallies 313 as Bulls Eye Resistance at 1902 Entergy ETR Stock Edges Lower as Utility Sector Faces Mixed Sentiment SOLV Energy MWH Rallies Above Key Support Approaching Resistance Zone Credit Suisse High Yield Credit Fund DHY Slips 14 Support Levels in Focus ADP Reports Private Payrolls Rise 109000 in April Exceeding Expectations Astronics Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Despite Limited Revenue Disclosure Royalty Pharma RPRX Holds Ground Near Midpoint Steady Trading in Tight Range